Roche recalls stolen Italian Herceptin
This article was originally published in Scrip
Executive Summary
Roche has issued a recall of vials of Herceptin (trastuzumab) in Italy, thought to have been stolen and tampered with.
You may also be interested in...
UK MHRA Starts Internal Review Over Stolen Drug Revelations
The UK MHRA has reacted to a television program on the sale in the UK of medicines stolen in Italy in 2014 by launching an internal review of actions taken at the time. It remains to be seen how effective the EU's new system for detecting falsified medicines will be in preventing the trafficking of stolen drugs.
WuXi eases CAR-T manufacturing burden with new US plant
China's WuXi PharmaTech, an R&D technology company serving the pharmaceutical, biotechnology and medical device industries, has announced construction of a new manufacturing facility in Philadelphia, US designed for cell therapy products, including chimeric antigen receptor T-cell (CAR-T) therapies. More manufacturing power is crucial to the success of this burgeoning, high-potential field.
NICE lifts Entyvio restrictions after Takeda offers discount
Takeda has managed to persuade NICE, the health technology appraisal institute for England and Wales, to recommend its ulcerative colitis drug Entyvio (vedolizumab) without the restrictions the institute had previously stipulated – as long as the company offers a discount via a patient access scheme.